AArjuna Therapeutics — Seed (estimated) · €1.5M
Arjuna Therapeutics is a University of Santiago de Compostela spin-out developing Therapeutic Molecular Clusters, led by Ag5, against pancreatic cancer and glioblastoma. It closed a €1.5M round through an equity crowdfunding campaign on Capital Cell, reaching 125% of its target; parent company Nanogap and specialist investors from the UK and Silicon Valley also took part.
LeadNanogap
RoundSeed (estimated)
Announced2 Dec 2022
CityA Coruña · reported Milladoiro
SectorHealthtech & Bio · Biotech / Oncology
Source
W
W
